BriaCell Therapeutics Corp. (BCTX): Free Cash Flow
-$28.78M
Year ended 2026-07-31
| Period ended | Free Cash Flow | Change YoY | Source filing |
|---|---|---|---|
| 2026-07-31 | -$28.78M | n/a | 2026-10-28, From 2025-08-01 |
| No annual figure between 2024-07-31 and 2026-07-31. | |||
| 2024-07-31 | -$24.58M | n/a | 2025-10-16, From 2023-08-01 |
Free Cash Flow at similar companies
| Company | Year ended | Free Cash Flow | Change YoY |
|---|---|---|---|
| BriaCell Therapeutics Corp. (BCTX) | 2026-07-31 | -$28.78M | n/a |
| Immunic, Inc. (IMUX) | 2025-12-31 | -$85.97M | n/m |
| Kiora Pharmaceuticals Inc (KPRX) | 2025-12-31 | -$10.07M | n/m |
| Faeth Therapeutics, Inc. (FTH) | 2025-12-31 | -$20.47M | n/m |
| HCW Biologics Inc. (HCWB) | 2025-12-31 | -$13.39M | n/m |
| Moleculin Biotech, Inc. (MBRX) | 2025-12-31 | -$22.73M | n/m |
| Integrated Biopharma Inc (INBP) | 2026-06-30 | $895.0K | -52.2% |
| CASI Pharmaceuticals, Inc. (CASIF) | 2025-12-31 | -$20.77M | n/m |
| Elicio Therapeutics, Inc. (ELTX) | 2025-12-31 | -$36.97M | n/m |
Compare BCTX, IMUX, KPRX, FTH side by side · Screen every company in Pharmaceutical Preparations ↗